We are live on ! Find out more
EMG

ETF Managers Group Portfolio holdings

AUM $3.1B
1-Year Est. Return 17.12%
This Fund
S&P 500
This Quarter Est. Return
+18.48%
1 Year Est. Return
-17.12%
3 Year Est. Return
+77.69%
5 Year Est. Return
+63.88%
10 Year Est. Return
–
AUM
$5.63B
AUM Growth
+$1.07B
Cap. Flow
+$732M
Cap. Flow %
13%
Top 10 Hldgs %
19.89%
Holding
695
New
78
Increased
409
Reduced
177
Closed
27

Top Buys

Rank Stock Value
1
CGNT icon
Cognyte Software
CGNT
+$51.8M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$45.4M
3
MATV icon
Mativ Holdings
MATV
+$37.9M
4
ARNA
Arena Pharmaceuticals Inc
ARNA
+$37.4M
5
MO icon
Altria Group
MO
+$34.6M

Top Sells

Rank Stock Value
1
TLRY icon
Tilray
TLRY
+$43M
2
APHA
Aphria Inc. Common Shares
APHA
+$40M
3
VRNT
Verint Systems
VRNT
+$35.2M
4
GME icon
GameStop
GME
+$18.6M
5
ABST
Absolute Software Corp
ABST
+$18M

Sector Composition

Rank Sector Weight
1 Technology 42.31%
2 Healthcare 18.48%
3 Materials 13.25%
4 Financials 7.76%
5 Consumer Staples 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IFRX icon
651
InflaRx
IFRX
$327M
$51K ﹤0.01%
+13,326
New +$68.2K
ENZ
652
DELISTED
Enzo Biochem, Inc.
ENZ
$48K ﹤0.01%
14,671
-8,625
-37% -$26.8K
LNAI
653
Lunai Bioworks
LNAI
$10.8M
$47K ﹤0.01%
179
-105
-37% -$30.9K
EGIO
654
DELISTED
Edgio, Inc. Common Stock
EGIO
$45K ﹤0.01%
323
– –
CFRX
655
DELISTED
ContraFect Corporation
CFRX
$38K ﹤0.01%
106
-63
-37% -$27.2K
EVAX
656
Evaxion A/S
EVAX
$28.1M
$31K ﹤0.01%
+118
New +$45.2K
PHAS
657
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$29K ﹤0.01%
8,995
-5,288
-37% -$21.5K
XERS icon
658
Xeris Biopharma Holdings
XERS
$1.56B
$23K ﹤0.01%
5,428
+1,056
+24% +$5.7K
VTRS icon
659
Viatris
VTRS
$19.4B
$17K ﹤0.01%
1,230
-1,360
-53% -$22.2K
SRNE
660
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$9K ﹤0.01%
1,092
-115,329
-99% -$1.22M
HLI icon
661
Houlihan Lokey
HLI
$9.58B
$6K ﹤0.01%
96
-12,549
-99% -$847K
DMK
662
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$6K ﹤0.01%
+89
New +$6.93K
PHM icon
663
Pultegroup
PHM
$23.7B
$4K ﹤0.01%
78
-5,548
-99% -$259K
XELA
664
DELISTED
Exela Technologies, Inc. Common Stock
XELA
– –
0
– –
COTY icon
665
Coty
COTY
$2.58B
$2K ﹤0.01%
216
-186,567
-100% -$1.42M
TROX icon
666
Tronox
TROX
$768M
$2K ﹤0.01%
100
-14,380
-99% -$251K
NVTA
667
DELISTED
Invitae Corporation
NVTA
$2K ﹤0.01%
55
-10,120
-99% -$460K
USWS
668
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$2K ﹤0.01%
+89
New +$2.31K
ASIX icon
669
AdvanSix
ASIX
$471M
– –
-6,013
Closed -$120K
NXH
670
Neighborhood Intelligence Inc
NXH
$377M
– –
-1,752
Closed -$84K
CGNX icon
671
Cognex
CGNX
$10.5B
– –
-7,057
Closed -$571K
CPB icon
672
Campbell Soup
CPB
$6.38B
– –
-13,248
Closed -$636K
CTLP
673
DELISTED
Cantaloupe
CTLP
– –
-296,672
Closed -$3.1M
FRT icon
674
Federal Realty Investment Trust
FRT
$10.2B
– –
-1,883
Closed -$160K
LOCO icon
675
El Pollo Loco
LOCO
$468M
– –
-13,456
Closed -$245K
24 25 26
27
28

Similar funds

AIA
Avalon Investment & Advisory Houston, Texas $3.65B AUM 0.47% 1-Year Est. Return
PFM
Parsec Financial Management Asheville, North Carolina $2.37B AUM 4.66% 1-Year Est. Return
DKP
Davidson Kempner Partners New York $5.16B AUM
HT
HighTower Trust Houston, Texas $1.02B AUM 4.1% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
QA
Quantitative Advantage Minnetonka, Minnesota $689M AUM 6.25% 1-Year Est. Return
BFG
Barber Financial Group Lenexa, Kansas $567M AUM 5.25% 1-Year Est. Return
IMOV
Investment Management of Virginia Richmond, Virginia $526M AUM 3.23% 1-Year Est. Return

ETF Managers Group's Q1 2021 Portfolio in Review

As of Q1 2021, ETF Managers Group held 695 positions worth $5.63B, up 23% from $4.56B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

ETF Managers Group deployed $732M of net new capital in Q1 2021, opening 78 new positions and adding to 409 existing holdings. Its largest new stake was Cognyte Software: 1,743,286 shares worth $47.8M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 52% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Tilray, an estimated $43M trimmed.

  • ETF Managers Group's largest Q1 2021 buy was Cognyte Software: 1,743,286 shares worth $47.8M.
  • ETF Managers Group added most to GW Pharmaceuticals Plc American Depositary Shares in Q1 2021, an estimated $45.4M increase.
  • ETF Managers Group's biggest Q1 2021 reduction was Tilray, cutting an estimated $43M.
  • ETF Managers Group fully exited Tvardi Therapeutics in Q1 2021, selling an estimated $6.57M.
  • ETF Managers Group's ten largest holdings make up 20% of its $5.63B portfolio in Q1 2021.
  • ETF Managers Group opened 78 new positions and closed 27 in Q1 2021.
  • ETF Managers Group's portfolio value rose 23% quarter-over-quarter to $5.63B.

Based on ETF Managers Group's 13F filing for Q1 2021, filed 17 May 2021.